Annual Revenue Comparison: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.

Biotech Giants: Lantheus vs. PTC Revenue Growth

__timestampLantheus Holdings, Inc.PTC Therapeutics, Inc.
Wednesday, January 1, 201430160000022963000
Thursday, January 1, 201529346100036766000
Friday, January 1, 201630185300082705000
Sunday, January 1, 2017331378000194392000
Monday, January 1, 2018343374000264734000
Tuesday, January 1, 2019347337000306980000
Wednesday, January 1, 2020339410000380766000
Friday, January 1, 2021425208000538593000
Saturday, January 1, 2022935061000698801000
Sunday, January 1, 20231296429000937822000
Loading chart...

In pursuit of knowledge

A Decade of Growth: Lantheus Holdings vs. PTC Therapeutics

In the ever-evolving landscape of the biotechnology sector, Lantheus Holdings, Inc. and PTC Therapeutics, Inc. have emerged as notable players. Over the past decade, Lantheus Holdings has demonstrated a remarkable revenue growth trajectory, with a staggering 330% increase from 2014 to 2023. This growth is highlighted by a significant leap in 2022, where revenues nearly doubled compared to the previous year.

PTC Therapeutics, while starting from a lower base, has also shown impressive growth, with revenues increasing by over 400% during the same period. The year 2023 marked a milestone for PTC, as it achieved its highest annual revenue, closing the gap with Lantheus.

This comparison not only underscores the dynamic nature of the biotech industry but also highlights the strategic advancements and market adaptability of these two companies.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025